Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1991 Mar;87(3):1032–1036. doi: 10.1172/JCI115062

Propranolol ameliorates the development of portal-systemic shunting in a chronic murine schistosomiasis model of portal hypertension.

S K Sarin 1, R J Groszmann 1, P G Mosca 1, M Rojkind 1, M J Stadecker 1, R Bhatnagar 1, A Reuben 1, Y Dayal 1
PMCID: PMC329897  PMID: 1900306

Abstract

We investigated the role of early portal hypotensive pharmacotherapy in preventing the development of portal-systemic shunting in a portal hypertensive model of chronic murine schistosomiasis induced by infecting C3H mice with 60 cercariae of Schistosoma mansoni. Propranolol was administered in drinking water to 20 animals for a period of 6 wk at a dose of 10 mg.kg-1d-1, starting at 5 wk of schistosomal infection. 32 age-matched mice with chronic schistosomal infection served as controls. All animals were studied 11 wk after the infection. Compared with controls the portal pressure (10.8 +/- 0.40 mmHg) was significantly lower (P less than 0.001) in the propranolol-treated animals (7.9 +/- 0.80 mmHg). Portal-systemic shunting was decreased by 79%, from 12.2 +/- 3.34% in controls to 2.5 +/- 0.99% in the propranolol group (P less than 0.05). Portal venous inflow was reduced by 38% in the propranolol treated animals (2.50 +/- 0.73 ml/min; n = 6) compared with controls (4.00 +/- 0.34 ml/min; n = 8; P less than 0.05). The worm burden, the granulomatous reaction, the collagen content of the liver, and the serum bile acid levels were not significantly different between the two groups of animals. These results demonstrate that in chronic liver disease induced by schistosomiasis, the development of portal-systemic shunting can be decreased or prevented by the reduction of flow and pressure in the portal system.

Full text

PDF
1032

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Benoit J. N., Barrowman J. A., Harper S. L., Kvietys P. R., Granger D. N. Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension. Am J Physiol. 1984 Nov;247(5 Pt 1):G486–G493. doi: 10.1152/ajpgi.1984.247.5.G486. [DOI] [PubMed] [Google Scholar]
  2. Chojkier M., Groszmann R. J. Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres. Am J Physiol. 1981 May;240(5):G371–G375. doi: 10.1152/ajpgi.1981.240.5.G371. [DOI] [PubMed] [Google Scholar]
  3. Dunn M. A., Kamel R. Hepatic schistosomiasis. Hepatology. 1981 Nov-Dec;1(6):653–661. doi: 10.1002/hep.1840010615. [DOI] [PubMed] [Google Scholar]
  4. Groszmann R. J., Bosch J., Grace N. D., Conn H. O., Garcia-Tsao G., Navasa M., Alberts J., Rodes J., Fischer R., Bermann M. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 1990 Nov;99(5):1401–1407. doi: 10.1016/0016-5085(90)91168-6. [DOI] [PubMed] [Google Scholar]
  5. Hillon P., Blanchet L., Lebrec D. Effect of propranolol on hepatic blood flow in normal and portal hypertensive rats. Clin Sci (Lond) 1982 Jul;63(1):29–32. doi: 10.1042/cs0630029. [DOI] [PubMed] [Google Scholar]
  6. Kobayashi K., Allen R. M., Bloomer J. R., Klatskin G. Enzymatic fluorometry for estimating serum total bile acid concentration. JAMA. 1979 May 11;241(19):2043–2045. [PubMed] [Google Scholar]
  7. Kroeger R. J., Groszmann R. J. Effect of selective blockade of beta 2-adrenergic receptors on portal and systemic hemodynamics in a portal hypertensive rat model. Gastroenterology. 1985 Apr;88(4):896–900. doi: 10.1016/s0016-5085(85)80005-6. [DOI] [PubMed] [Google Scholar]
  8. Lebrec D., Poynard T., Hillon P., Benhamou J. P. Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study. N Engl J Med. 1981 Dec 3;305(23):1371–1374. doi: 10.1056/NEJM198112033052302. [DOI] [PubMed] [Google Scholar]
  9. López-De León A., Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem. 1985 Aug;33(8):737–743. doi: 10.1177/33.8.2410480. [DOI] [PubMed] [Google Scholar]
  10. Morgan J. S., Groszmann R. J., Rojkind M., Enriquez R. Hemodynamic mechanisms of emerging portal hypertension caused by schistosomiasis in the hamster. Hepatology. 1990 Jan;11(1):98–104. doi: 10.1002/hep.1840110117. [DOI] [PubMed] [Google Scholar]
  11. Ohkubo H., Okuda K., Iida S., Ohnishi K., Ikawa S., Makino I. Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis. Gastroenterology. 1984 Mar;86(3):514–520. [PubMed] [Google Scholar]
  12. Ohlsson E. G., Rutherford R. B., Boitnott J. K., Haalebos M. M., Zuidema G. D. Changes in portal circulation after biliary obstruction in dogs. Am J Surg. 1970 Jul;120(1):16–22. doi: 10.1016/s0002-9610(70)80135-0. [DOI] [PubMed] [Google Scholar]
  13. Pons H. A., Morgan J. S., Hutchinson M. L., Rojkind M., Groszmann R. J., Stadecker M. J. Resistance to reinfection in experimental murine schistosomiasis: role of porto-hepatic hemodynamics. Am J Trop Med Hyg. 1989 Aug;41(2):189–197. [PubMed] [Google Scholar]
  14. Reichen J., Egger B., Ohara N., Zeltner T. B., Zysset T., Zimmermann A. Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis. J Clin Invest. 1988 Dec;82(6):2069–2076. doi: 10.1172/JCI113828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Sarin S. K., Sabba C., Groszmann R. J. Splanchnic and systemic hemodynamics in mice using a radioactive microsphere technique. Am J Physiol. 1990 Mar;258(3 Pt 1):G365–G369. doi: 10.1152/ajpgi.1990.258.3.G365. [DOI] [PubMed] [Google Scholar]
  16. Sikuler E., Kravetz D., Groszmann R. J. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model. Am J Physiol. 1985 Jun;248(6 Pt 1):G618–G625. doi: 10.1152/ajpgi.1985.248.6.G618. [DOI] [PubMed] [Google Scholar]
  17. Smithers S. R., Terry R. J. The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms. Parasitology. 1965 Nov;55(4):695–700. doi: 10.1017/s0031182000086248. [DOI] [PubMed] [Google Scholar]
  18. Vorobioff J., Bredfeldt J. E., Groszmann R. J. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension. Am J Physiol. 1983 Jan;244(1):G52–G57. doi: 10.1152/ajpgi.1983.244.1.G52. [DOI] [PubMed] [Google Scholar]
  19. Vorobioff J., Bredfeldt J. E., Groszmann R. J. Increased blood flow through the portal system in cirrhotic rats. Gastroenterology. 1984 Nov;87(5):1120–1126. [PubMed] [Google Scholar]
  20. WARREN K. S., DEWITT W. B. Production of portal hypertension and esophageal varices in the mouse. Proc Soc Exp Biol Med. 1958 May;98(1):99–101. doi: 10.3181/00379727-98-23952. [DOI] [PubMed] [Google Scholar]
  21. el-Meneza S., Olds G. R., Kresina T. F., Mahmoud A. A. Dynamics of hepatic connective tissue matrix constituents during murine Schistosoma mansoni infection. Hepatology. 1989 Jan;9(1):50–56. doi: 10.1002/hep.1840090108. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES